Comanche Biopharma: Funding, Investors & Team (Sep 2026)
Comanche Biopharma is a biopharmaceutical company focused on creating siRNA therapy specifically designed to address preeclampsia. The objective of the company is to minimize the dangers associated with pregnancy and premature birth, enabling a safe and healthy progression of natural pregnancies while ensuring the proper development of the fetus.
Comanche Biopharma has raised $111M across 2 funding rounds on record, the most recent a Series B of $75.0M announced in Jan 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Comanche Biopharma Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Comanche Biopharma Funding Rounds
Comanche Biopharma raised $36.1M in an undisclosed round announced in May 2023.
8 months later, a Series B of $75.0M was announced in Jan 2024.
Comanche Biopharma Founders and Leadership Team
Contact details for the Comanche Biopharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Comanche Biopharma Funding Compared to Other Biotechnology Startups
Comanche Biopharma's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Comanche Biopharma in Biotechnology and Concord
Companies Similar to Comanche Biopharma
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Comanche Biopharma Funding FAQs
What does Comanche Biopharma do?
Comanche Biopharma is a biopharmaceutical company focused on creating siRNA therapy specifically designed to address preeclampsia. The objective of the company is to minimize the dangers associated with pregnancy and premature birth, enabling a safe and healthy progression of natural pregnancies while ensuring the proper development of the fetus.
How much funding has Comanche Biopharma raised?
Comanche Biopharma has raised $111M across 2 rounds on record. The most recent is a Series B of $75.0M announced in Jan 2024.
When did Comanche Biopharma last raise funding?
Comanche Biopharma's most recent funding round on record is a Series B of $75.0M, announced in Jan 2024.
Who founded Comanche Biopharma?
FundedIQ lists Mike Young (Founder) at Comanche Biopharma.
Where is Comanche Biopharma headquartered?
Comanche Biopharma is based in Concord, Massachusetts, United States.
How many employees does Comanche Biopharma have?
Comanche Biopharma is in the 11-50 employee band.
How does Comanche Biopharma's funding compare to other Biotechnology startups?
Comanche Biopharma's latest round of $75.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Comanche Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Comanche Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.